Connect to other sites within the UBM Medica Network
Four questions for you to answer, four facts you need to know.
Diabetes: Mulling Jardiance Heart Benefit
The empagliflozin CV benefit was "astounding" and a first for any diabetes drug, but what does it actually mean?
Poor Glycemic Control Boosts Dementia Risk
A Swedish study found that patients with A1c greater than 10% had a 23% greater risk of developing dementia than those whose A1C was less than 6%.
Sleep Disorders and Glucose Metabolism: What's the Connection?
Common sleep disorders appear to worsen insulin resistance, glucose intolerance, and pancreatic endocrine dysfunction. Here, a closer look at how.
Erectile Dysfunction Doubles Diabetes Risk
ED may raise the risk of diabetes, coffee may lower it, and the evidence against sugary drinks continues to mount.
GLP-1 Agonist Pop Quiz
Take a short break from the clinic and try 2 quick questions about the injectable gut hormone analogs.
3 Weighty Questions About Obesity and Diabetes
Questions you were afraid to ask about weight-loss modalities in the context of obesity and type 2 diabetes are answered here.
Combo Diet-Exercise Programs Trim Diabetes Risk
In the diabetes news: diet and physical activity programs may help prevent type 2 DM, patiromer shows promise for hyperkalemia, metformin may treat portal hypertension.
Abridged Diabetes Guidelines for Primary Care: 6 Noteworthy Changes
The ADA provides an abridged version for PCPs of its annual Standards of Medical Care. Our slides summarize 6 updates important to primary care.
Five Top Papers From 2014 That Will Impact Your Practice
New drugs that treat stubborn illness seen often in primary care lead this group of Top 5 Papers for 2014. Type 2 diabetes, cryptogenic stroke, and hep-C are key targets.
By clicking Accept, you agree to become a member of the UBM Medica Community.